Prospective, randomized controlled trial on use of ropivacaine after robotic thyroid surgery: Effects on postoperative pain

Dong Sik Bae, Su Jin Kim, Do Hoon Koo, Se Hyun Paek, Hyungju Kwon, Young Jun Chai, June Young Choi, Kyu Eun Lee, Yeo Kyu Youn

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Background We evaluated the effects of ropivacaine for pain relief after robotic thyroid surgery. Methods One hundred eight patients scheduled for robotic thyroid surgery were randomized into ropivacaine (n = 54) or control (n = 54) groups. After surgery, 40 mL of 0.25% ropivacaine or 0.9% saline (control) was instilled into the skin flap. Postoperative pain intensity (visual analog scale [VAS]), analgesic requirements (fentanyl), and adverse events were assessed at 1, 2, 4, 8, 16, and 24 hours postoperatively. Results One hundred three patients completed the study protocol. VAS scores were lower in the ropivacaine group than the control group (p =.010); however, VAS scores were not significantly different after 8 hours postoperatively. Total analgesic consumption was higher in controls than ropivacaine-treated patients (p =.01). Adverse events did not differ between the 2 groups. Conclusion Ropivacaine instillation after robotic thyroid surgery reduces acute postoperative pain and analgesic requirements without adverse events.

Original languageEnglish
Pages (from-to)E588-E593
JournalHead and Neck
Volume38
DOIs
StatePublished - 1 Apr 2016

Keywords

  • acute pain
  • bilateral axillo-breast approach (BABA)
  • postoperative pain
  • robotic thyroid surgery
  • ropivacaine

Fingerprint

Dive into the research topics of 'Prospective, randomized controlled trial on use of ropivacaine after robotic thyroid surgery: Effects on postoperative pain'. Together they form a unique fingerprint.

Cite this